Pushpa Sran

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Robert B. Nussenblatt, Éric Fortin, Rhett M. Schiffman et al. · Proceedings of the National Academy of Sciences · 1999 · 260 citations

Medicine, Immunology, Ophthalmology +17

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Robert B. Nussenblatt, Darby J. S. Thompson, Zhuqing Li et al. · Journal of Autoimmunity · 2003 · 119 citations

Medicine, Immunology, Pharmacotherapy +15

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis

Steven Yeh, Keith J. Wroblewski, Ronald Buggage et al. · Journal of Autoimmunity · 2008 · 84 citations · Full text

Medicine, Immunology, Pharmacology +12

Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease

Keith J. Wroblewski, H. Nida Sen, Steven Yeh et al. · Canadian Journal of Ophthalmology · 2011 · 49 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +11

A Masked, Randomized, Dose-response Study Between Cyclosporine A and G in the Treatment of Sight-threatening Uveitis of Noninfectious Origin

Robert B. Nussenblatt, Marc D. de Smet, Benjamin Rubin et al. · American Journal of Ophthalmology · 1993 · 32 citations

Medicine, Ophthalmology, Pharmacology +11